title: Combination treatment for hepatitis C can be hazardous in patients co-infected with HIV.
authors.forename: R
authors.initials: R
authors.lastname: Schvarcz
authors.forename: L
authors.initials: L
authors.lastname: Moberg
authors.forename: A
authors.initials: A
authors.lastname: Sönnerborg
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects; D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000276:immunology*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D012254:Ribavirin / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin